GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » 3-Year EBITDA Growth Rate

Amoy Diagnostics Co (SZSE:300685) 3-Year EBITDA Growth Rate : 15.90% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co 3-Year EBITDA Growth Rate?

Amoy Diagnostics Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.18.

During the past 12 months, Amoy Diagnostics Co's average EBITDA Per Share Growth Rate was 3.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 15.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Amoy Diagnostics Co was 47.60% per year. The lowest was 6.40% per year. And the median was 18.15% per year.


Competitive Comparison of Amoy Diagnostics Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Amoy Diagnostics Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amoy Diagnostics Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Amoy Diagnostics Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Amoy Diagnostics Co's 3-Year EBITDA Growth Rate falls into.



Amoy Diagnostics Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Amoy Diagnostics Co  (SZSE:300685) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Amoy Diagnostics Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Amoy Diagnostics Co (SZSE:300685) Business Description

Traded in Other Exchanges
N/A
Address
39 Dingshan Road, Haicang District, Xiamen, CHN, 361027
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Amoy Diagnostics Co (SZSE:300685) Headlines

No Headlines